VISCODERM® SKINKÒ E + VISCODERM® SKINKÒ KIT

Description

Name:VISCODERM® SKINKÒ E + VISCODERM® SKINKÒ KIT
Manufacturer: IBSA
Active Substance(s): HYALURONIC ACID
Strength: 32mg/5ml
Pack Size: 5ML Vial and 10 Syringes
Package Content: 10 x 5ml Vials and 10 Syringes, 10 x 30GX4mm UTW, 10 x 25GX16mm, 10 x 30GX12mm TW Needles

VISCODERM® SKINKÒ E and VISCODERM® SKINKÒ KIT are advanced injectable treatments formulated to improve the appearance of the skin through deep hydration, anti-aging action, and tissue revitalization. Developed for professional use, they offer tailored solutions for different degrees of skin aging, ensuring natural-looking rejuvenation without altering facial expressions.

Key Features:

• Dual Formulation: VISCODERM® SKINKÒ E contains 32 mg of non-crosslinked hyaluronic acid per 5 ml vial, while VISCODERM® SKINKÒ offers 2 mg per 5 ml vial, allowing customized treatments.
• Rich Anti-aging Complex: Includes a combination of vitamins, amino acids, minerals, and antioxidants to nourish and protect the skin.
• Flexible Application Techniques: Compatible with nappage, point-by-point, retrotracing, fan injection, and transdermal systems for versatile treatment strategies.
  

The packaging of VISCODERM® SKINKÒ E + VISCODERM® SKINKÒ KIT is designed to maintain sterility and ensure easy handling. Each kit contains a case of 10 x 5 ml vials, with clear, colorless injectable solutions provided in sterile vials intended for single-use only.

Ingredients:

• Non-Crosslinked Hyaluronic Acid:
  
  • VISCODERM® SKINKÒ E: 32 mg/5 ml.
  • VISCODERM® SKINKÒ: 2 mg/5 ml.
• Buffered Medium: Includes essential minerals like calcium chloride, magnesium chloride, zinc sulfate, and trace elements like selenium and nickel chloride.
• Amino Acids and Vitamins: Contains Alanine, Glycine, Vitamin B1 (Thiamine), Vitamin B6 (Pyridoxine), Vitamin B12, among others, promoting skin repair and cellular metabolism.
• Antioxidants: Lipoic Acid and other co-factors to neutralize free radicals.
  

This section details the recommended clinical use cases, contraindications, and potential side effects associated with the product. Proper patient selection and adherence to guidelines ensure safe and effective outcomes.

Indications:

• VISCODERM® SKINKÒ: Improves hydration and reduces fine lines.
• VISCODERM® SKINKÒ E: Reduces wrinkles and fine lines, enhances cheek volume, particularly beneficial in periorbital and perioral areas.
  

Contraindications:

• Hypersensitivity to any product component.
• Active skin diseases or damage in the treatment area.
• Patients with a history of autoimmune diseases.
• Use in pregnant or lactating women or individuals under 18 years of age.
  

Side Effects:

• Pain, redness, stinging, and mild edema immediately post-injection, generally resolving within 24–48 hours.
• Small hematomas may develop but usually disappear within 2 days.
• Rarely, longer-lasting adverse events requiring medical evaluation.
  

Administering VISCODERM® SKINKÒ E and SKINKÒ requires skilled technique and adherence to strict aseptic procedures to maximize results and minimize complications.

Method of Use:

• Injection into the superficial to middle dermis using techniques appropriate to the formulation:
  
  • VISCODERM® SKINKÒ: Nappage, papules, point-by-point, transdermal systems.
  • VISCODERM® SKINKÒ E: Point-by-point, retrotracing, fan injection, cross-hatching, transdermal systems.
    
• Recommended Protocol:
  
  • Initial treatment: 3 sessions spaced one week apart.
  • Maintenance: Sessions every 1–2 months, depending on the patient’s skin condition and aesthetic goals.

Storage Conditions:

• Store between 2°C and 30°C.
• Protect from light, freezing, and excessive heat.
• Use immediately after opening; any remaining solution must be discarded.
• Maintain original secondary packaging to prevent contamination or degradation.

Warning! The product is intended solely for professional use in a medical environment and under professional supervision. The product is supplied to medical professionals who specialize in aesthetic medicine (plastic surgery, facial treatments) and work under individual medical licenses as aestheticians or in dedicated clinics. Unprofessional use by individuals without a medical background may lead to severe adverse effects and health harm.